|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03880 MEDTIDE
Nominal 
30.600 -0.280 (-0.907%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 120,507 | 88,327 | 134,798 |
| Net Cash from / (used in) Investing Activities | 5,153 | 182,426 | (350,932) |
| Net Cash from / (used in) Financing Activities | (276,471) | (23,726) | (60,085) |
| Increase / (Decrease) in Cash & Cash Equivalents | (150,811) | 247,027 | (276,219) |
| Cash & Cash Equivalents at beginning of period | 531,012 | 279,048 | 538,264 |
| Effect of Foreign Exchange Rate Changes | 6,982 | 4,937 | 17,003 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 387,183 | 531,012 | 279,048 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 101,999 |
| %Change | 101.711% |
| EPS / (LPS) | RMB 0.820 |
| NBV Per Share (¥) | RMB 10.359 |